Here's Why Johnson & Johnson Jumped Higher Today
Shares of Johnson & Johnson (NYSE: JNJ) are up 6.4% at 1:50 p.m. EDT after the healthcare conglomerate said it's made considerable progress developing a vaccine for COVID-19, the disease caused by the novel coronavirus.
Earlier this month Johnson & Johnson's chief scientific officer, Dr. Paul Stoffels, said the company had a goal of starting a clinical trial in November, but Johnson & Johnson now thinks it can be in the clinic by September at the latest.
Image source: Getty Images.
Source Fool.com
